Endoluminal therapy has become the first-choice treatment over the last 5 years for early
Barrett's neoplasia limited to the mucosa. Long-term follow-up data on endoscopic resection …

Background Barrett's esophagus (BE) is the most important identifiable risk factor for the
progression to esophageal adenocarcinoma. Methods This article reviews the current …

Background: Endoscopic resection (ER) has gained more and more importance in the
treatment of early neoplasia in Barrett's esophagus. As long as there has been no long-term …

The incidence of adenocarcinoma of the distal esophagus is increasing at an alarming rate.
Intestinal metaplasia in the distal esophagus, ie Barrett's esophagus, has been identified as …

Endoscopic therapy of Barrett's esophagus is feasible and likely to decrease the future risk
of development of esophageal adenocarcinoma. The most commonly utilized therapy is …

Barrett's esophagus (BE) is an acquired condition characterized by replacement of stratified
squamous epithelium by a cancer predisposing metaplastic columnar epithelium …

Besides esophagectomy and antireflux therapy with intensive endoscopic surveillance,
endoscopic ablation therapy is a new treatment modality for Barrett's esophagus (BE) with …

Endoscopic resection (ER) has gained more and more importance in the treatment of early
neoplastic lesions in Barrett's oesophagus over the last few years. The choice of the different …

Endoscopic management options for Barrett's esophagus with high-grade dysplasia consists
of either surveillance methods or endoscopic mucosal ablative therapies. Once a person is …

Barrett's oesophagus (BO) is the only known precursor to oesophageal adenocarcinoma
(OAC). Dysplasia and intramucosal cancer arising in BO can safely be treated with …